XML 30 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity
3 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Equity
Equity

Equity Plans
We provide long-term incentives to eligible officers, directors, and employees in the form of equity-based awards. We maintain three equity incentive compensation plans, collectively described below as our “Equity Plans”:

the 2000 Stock Option Plan,
the 2010 Equity Incentive Plan (“2010 Plan”), and
the 2012 Equity Incentive Plan (“2012 Plan”).

We issue new shares of common stock to satisfy awards issued under our Equity Plans.

Stock Options
Most of our stock options vest and become exercisable over a four to five year period and have a contractual life of 10 years. Certain stock options awarded are intended to qualify as incentive stock options pursuant to Section 422A of the Internal Revenue Code.

The following table summarizes stock option activity under the Equity Plans for the three months ended December 31, 2018:


Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average
Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2018
69,980

 
$4.74
 
 
 
 
Granted

 

 
 
 
 
Exercised

 

 
 
 

Forfeited
(52
)
 
$3.97
 
 
 
 
Expired
(1,267
)
 
$5.21
 
 
 
 
Outstanding as of December 31, 2018
68,661

 
$4.73
 
4.93
 
$
11

Exercisable as of December 31, 2018
47,122

 
$4.77
 
4.04
 
$
10

Vested and expected to vest as of December 31, 2018
68,661

 
$4.73
 
4.93
 
$
11


(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the three months ended December 31, 2017, the intrinsic value of options exercised was $13,000.

As of December 31, 2018, there was approximately $44,000 of unrecognized stock-based compensation expense related to non-vested stock options granted under the Equity Plans which is expected to be recognized over an estimated weighted average life of 1.8 years.

Valuation Assumptions
There were no stock option grants for the three months ended December 31, 2018 and 2017.

Time-Based Restricted Stock
Time-based restricted stock units (“RSUs”) and restricted stock awards (“RSAs”) granted to employees under the 2010 Plan and 2012 Plan typically vest over 3 to 4 years and are subject to forfeiture if employment terminates prior to the lapse of the restrictions. RSUs are not considered issued or outstanding common stock until they vest. RSAs are considered issued and outstanding on the grant date and are subject to forfeiture if specified vesting conditions are not satisfied.

The following table summarizes the activity related to RSUs and RSAs subject to time-based vesting requirements for the three months ended December 31, 2018:

Restricted Stock Activity
 
Restricted Stock Units
 
Restricted Stock Awards
 
Number of Shares
 
Weighted Average Grant Date Fair Value
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2018
 
1,011,621

 
$6.04
 
8,154

 
$8.20
Granted
 
10,000

 
$4.48
 

 
$0.00
Vested
 
(93,422
)
 
$6.84
 

 
$0.00
Forfeited
 
(117,108
)
 
$4.73
 

 
$0.00
Non-vested as of December 31, 2018
 
811,091

 
$6.12
 
8,154

 
$8.20


As of December 31, 2018, there was approximately $4.1 million of remaining unamortized stock-based compensation expense associated with RSUs, which will be expensed over a weighted average remaining service period of approximately 2.7 years. The 0.8 million outstanding non-vested and expected to vest RSUs have an aggregate intrinsic value of approximately $3.4 million and a weighted average remaining contractual term of 1.6 years. For the three months ended December 31, 2018 and 2017, the intrinsic value of RSUs vested was approximately $0.4 million and $0.3 million, respectively. For the three months ended December 31, 2017, the weighted average grant date fair value of RSUs granted was $6.73 per share.

As of December 31, 2018, there was approximately $39,000 of remaining unamortized stock-based compensation expense associated with RSAs, which will be expensed over a weighted average remaining service period of approximately 1.8 years.

Performance Stock
Performance based restricted stock units (“PSUs”) and performance based shares of restricted stock (“PRSAs”) granted to employees under the 2012 Plan typically vest over 1 to 3 years and are subject to forfeiture in whole, if employment terminates, or in whole or in part, if specified vesting conditions are not satisfied, in each case prior to vesting. PSUs are not considered issued or outstanding common stock until they vest. PRSAs are considered issued and outstanding on the grant date (at 200% of the target number of shares) and are subject to forfeiture if specified vesting conditions are not satisfied. PSUs and PRSAs that are granted to our executive officers and key employees are provided as long-term incentive compensation that is based on relative total shareholder return, which measures our performance against that of our competitors.

The following table summarizes the activity related to PSUs and PRSAs for the three months ended December 31, 2018:

Performance Stock Activity
 
Performance Stock Units
 
Performance Stock Awards
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2018
 
397,777

 
$8.48
 
33,333

 
$12.25
Granted
 

 
$0.00
 

 
$0.00
Vested
 
(30,874
)
 
$7.14
 

 
$0.00
Forfeited
 
(132,579
)
 
$7.24
 

 
$0.00
Non-vested as of December 31, 2018
 
234,324

 
$9.35
 
33,333

 
$12.25


As of December 31, 2018, there was approximately $1.2 million of remaining unamortized stock-based compensation expense associated with PSUs, which will be expensed over a weighted average remaining service period of approximately 1.7 years. The 0.2 million outstanding non-vested and expected to vest PSUs have an aggregate intrinsic value of approximately $1.0 million and a weighted average remaining contractual term of 1.7 years. For the three months ended December 31, 2018 and 2017, the intrinsic value of PSUs vested was approximately $0.2 million and $1.4 million, respectively. For the three months ended December 31, 2017, the weighted average grant date fair value of PSUs granted was $7.62.

As of December 31, 2018, there was approximately $0.2 million of remaining unamortized stock-based compensation expense associated with PRSAs, which will be expensed over a weighted average remaining service period of approximately 0.8 years.

Stock-based compensation
The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type
For the three months ended December 31,
(in thousands)
2018
 
2017
Employee stock options
$
7

 
$
10

Restricted stock units and awards
386

 
451

Performance stock units and awards
(60
)
 
289

Employee stock purchase plan
40

 
86

Outside director equity awards and fees in common stock
52

 
79

Total stock-based compensation expense
$
425

 
$
915



Stock-based Compensation Expense - by expense type
For the three months ended December 31,
(in thousands)
2018
 
2017
Cost of revenue
$
111

 
$
139

Selling, general, and administrative
159

 
638

Research and development
155

 
138

Total stock-based compensation expense
$
425

 
$
915



Stock-based compensation within selling, general and administrative expense was lower for the three months ended December 31, 2018 due to the reversal of previously recognized expense associated with the forfeiture of unvested RSUs and PSUs of our former CFO Jikun Kim.

401(k) Plan
We have a savings plan that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Under this savings plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. Since June 2015, all employer contributions are made in cash. Our matching contribution in cash for the each of the three months ended December 31, 2018 and 2017 was approximately $0.1 million.

Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share:

Basic and Diluted Net Loss Per Share
 
For the three months ended December 31,
(in thousands, except per share)
 
2018
 
2017
Numerator:
 
 
 
 
   Loss from continuing operations
 
$
(5,538
)
 
$
(82
)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share
 
(5,538
)
 
(82
)
Denominator:
 
 
 
 
Denominator for basic and fully diluted net loss per share - weighted average shares outstanding
 
27,534

 
27,032

 
 
 
 
 
Net loss per basic and fully diluted share
 
$
(0.20
)
 
$

 
 
 
 
 
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation
 
664

 
911

 
 
 
 
 
Average market price of common stock
 
$
4.69

 
$
7.50



For diluted loss per share, the denominator includes all outstanding common shares and all potential dilutive common shares to be issued. The anti-dilutive stock options and unvested stock were excluded from the computation of diluted net loss per share for the three months ended December 31, 2018 and 2017 due to the Company incurring a net loss for the period.
Employee Stock Purchase Plan
We maintain an Employee Stock Purchase Plan (“ESPP”) that provides employees an opportunity to purchase common stock through payroll deductions. The ESPP is a 6-month duration plan with new participation periods beginning on approximately February 25 and August 26 of each year. The purchase price is set at 85% of the average high and low market price of our common stock on either the first or last trading day of the participation period, whichever is lower, and annual contributions are limited to the lower of 10% of an employee's compensation or $25,000.

Future Issuances 
As of December 31, 2018, we had common stock reserved for the following future issuances:
Future Issuances
Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options
68,661

Unvested restricted stock units
811,091

Unvested performance stock units and awards (at 200% maximum payout)
535,314

Purchases under the employee stock purchase plan
740,558

Issuance of stock-based awards under the Equity Plans
1,879,160

Purchases under the officer and director share purchase plan
88,741

Total reserved
4,123,525